171 related articles for article (PubMed ID: 3889253)
1. Management in the febrile, neutropenic patient with cancer: therapeutic considerations.
Brown AE
J Pediatr; 1985 Jun; 106(6):1035-42. PubMed ID: 3889253
[TBL] [Abstract][Full Text] [Related]
2. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
Furno P; Bucaneve G; Del Favero A
Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423
[TBL] [Abstract][Full Text] [Related]
7. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
[No Abstract] [Full Text] [Related]
8. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
Paul M; Soares-Weiser K; Leibovici L
BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
[TBL] [Abstract][Full Text] [Related]
9. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
Schimpff SC
Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
12. [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
Dejace P; Klastersky J
Infection; 1987; 15 Suppl 4():S158-67. PubMed ID: 3312028
[TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotic therapy for granulocytopenic cancer patients.
Schimpff SC
Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
Hathorn JW; Pizzo PA
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial therapy--special considerations in neutropenic patients.
Rodriguez V; Bodey GP
Clin Haematol; 1976 Jun; 5(2):347-60. PubMed ID: 181192
[No Abstract] [Full Text] [Related]
16. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Joshi JH; Newman KA; Brown BW; Finley RS; Ruxer RL; Moody MA; Schimpff SC
Support Care Cancer; 1993 Jul; 1(4):186-94. PubMed ID: 8193880
[TBL] [Abstract][Full Text] [Related]
17. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
18. Review of amikacin usage in the EORTC trials.
Zinner SH
Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
[TBL] [Abstract][Full Text] [Related]
19. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]